MarcDavidNatterMD
Pediatric Rheumatology • Boston, MAAdjunct Assistant Professor, Pediatrics, Tufts Medical Center
Are you Dr. Natter?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 41 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
55 Fruit St
# Yawkey
Boston, MA 02114Phone+1 617-726-2730Fax+1 617-724-0581
Summary
- Dr. Marc Natter, MD is a pediatric rheumatologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts, Vermont, and Connecticut. He is affiliated with Massachusetts General Hospital and Tufts Medical Center.
Education & Training
Tufts Medical CenterFellowship, Pediatric Rheumatology, 2004 - 2007
Albany Medical CenterResidency, Pediatrics, 2002 - 2004
Indiana University School of Medicine/Methodist HospitalInternship, Transitional Year, 2001 - 2002
Stony Brook University Health Sciences Center School of MedicineClass of 2001
Certifications & Licensure
MA State Medical License 2008 - 2025
VT State Medical License 2012 - 2024
CT State Medical License 2004 - 2010- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Rheumatology
Clinical Trials
- Single Patient Use of Tocilizumab in Systemic Onset Juvenile Idiopathic Arthritis Start of enrollment: 2009 Mar 01
- Pediatric Pulmonary Hypertension Network (PPHNet) Informatics Registry Start of enrollment: 2014 Oct 01
Publications & Presentations
PubMed
- 5 citationsThe Association of Black Cardiologists (ABC) Cardiovascular Implementation Study (CVIS): A Research Registry Integrating Social Determinants to Support Care for Unders...Elizabeth Ofili, Laura E. Schanberg, Barbara Hutchinson, Felix Sogade, Icilma Fergus
International Journal of Environmental Research and Public Health. 2019-05-10 - 73 citationsThe new Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry: design, rationale, and characteristics of patients enrolled in the first 12 months.Timothy Beukelman, Yukiko Kimura, Norman T. Ilowite, Kelly L. Mieszkalski, Marc D. Natter
Pediatric Rheumatology Online Journal. 2017-04-17 - 19 citationsAdding patient-reported outcomes to a multisite registry to quantify quality of life and experiences of disease and treatment for youth with juvenile idiopathic arthritisElissa R. Weitzman, Lauren E. Wisk, Parissa K. Salimian, Kara M. Magane, Fatma Dedeoglu
Journal of Patient-Reported Outcomes. 2018-01-04
Press Mentions
- Researchers Find Lower Risk of Severe COVID-19 Infection in Most Children with Juvenile Idiopathic ArthritisMarch 31st, 2022
- Infections, Low IgG Seen in Kids Receiving Rituximab for Rheumatic DiseaseAugust 19th, 2021
